Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender

Completed

• Conditions: Overweight; Obesity
• Interventions: Other: No treatment is given

• Registration Number: NCT06260696
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

The purpose of this survey is to collect information for scientific research and to identify the impact of overweight and obesity on health-related quality of life.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-08-10
• Primary Completion: 2023-10-05
• Study Completion: 2023-10-05
• Status Verified: 2024-02
• Study First Submitted: 2024-02-07
• Study First Submitted QC: 2024-02-07
• Last Update Submitted: 2024-02-07
• Study First Posted: 2024-02-15
• Last Update Posted: 2024-02-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Not currently pregnant
4. Does not participate in intense fitness or body building program
5. Weight loss not through illness or injury
6. Lives in South Korea, Australia, or India
7. BMI above or equal to 18 and associated weight class (Normal Weight or above) will be determined by a programmed calculation based on participant-reported height and weight.

Exclusion Criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study
2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
3. Does not meet inclusion criteria.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Overweight	No treatment is given	Adults with overweight, recruited to complete self-administered online service
Obesity Class I	No treatment is given	Adults with obesity class I, recruited to complete self-administered online service
Obesity Class II	No treatment is given	Adults with obesity class II, recruited to complete self-administered online service
Normal weight	No treatment is given	Adults with normal weight, recruited to complete self-administered online service
Obesity Class III	No treatment is given	Adults with obesity class III, recruited to complete self-administered online service

Primary Outcome Measures

Name	Time	Method
Score on IWQOL-Lite validated	At time of survey response (Day 1)	Calculated score. Likert scale; 1=Never True, 5=Always True

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇦🇪 Dubai, United Arab Emirates